Infrared Thermography Associated With Cutaneous Microcirculation for Detection of Brown-adipose Tissue (MICROBAT) (MICROBAT)

November 12, 2022 updated by: University of Avignon

Infrared Thermography Associated With Cutaneous Microcirculation for Detection of Brown-adipose Tissue: Proof of Concept Against PET-CT in Patients Affected by Pheochomocytoma and/or Paraganglioma

Patients affected by pheochromocytoma (PHEO) have brown-adipose tissue (BAT) hyperactivation. They perform, in routine settings, a FDG PET-CT scan. The high metabolic activity of BAT and its ability to consume both glucose and fatty acid suggest that it may have potential as a therapeutic target in the treatment of obesity. However, alternative non-invasive techniques to PET-CT BAT detection still need more validation. Accordingly, our aim will be to measure the temperature and microcirculation of the skin overlaying BAT depots in the region of FDG-uptake detected by 18F-FDG PET/CT before and after a cold test in PHEO patients.

Study Overview

Status

Recruiting

Detailed Description

Objectives and Methodology:

  • To analyse the change in temperature and microcirculation of the skin overlaying BAT depots in the region of FDG-uptake detected by 18F-FDG PET/CT before and after a cold test in PHEO patients.
  • To check the decreased temperature and microcirculatory response after a cold test following resection of the tumor

All the patients affected by will benefit from a:

  • clinical: treatments
  • biological evaluations: glycemia, triglycerides, total cholesterol, HDL-C, LDL-C, plasma epinephrine and norepinephrine, urine catecholamine
  • cutaneous microcirculation by means of Laser Speckle Imaging will be recorded at rest and during a cold test in the supra-clavicular region
  • cutaneous microcirculation by means of Laser Doppler Flowmetry will be recorded at rest and during a cold test with one probe in the supra-clavicular region and one probe in umbilical region
  • skin temperature by means of infrared thermography will be recorded at rest and during a cold test in the supra-clavicular region

Patients who will have surgery will be investigated before and after one year following resection of the tumor.

Study Type

Interventional

Enrollment (Anticipated)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Paca
      • Marseille, Paca, France, 13385
        • Recruiting
        • Pôle ENDO- Hopital la Conception APHM
        • Contact:
          • Vincent Amodru, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with confirmed pheochromocytoma and/or paraganglioma

Exclusion Criteria:

  • pregnant woman
  • breastfeeding woman

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: DIAGNOSTIC
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: BAT group

Patients will be divided in two groups for statistical analysis:

  • patients with detectable BAT by PET-CT (BAT+)
  • patients with no detectable BAT by PET-CT (BAT-)
measurement of temperature and microcirculation of the skin overlaying BAT depots in the region of FDG-uptake detected by 18F-FDG PET/CT before and after a cold test
Other Names:
  • Cutaneous microcirculation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Skin temperature in supra-clavicular region in basal condition (TSCRbasal)
Time Frame: Day 0
Skin temperature in supra-clavicular region will be recorded by infrared thermography (FLIR camera) in basal condition
Day 0
Skin temperature in supra-clavicular region during a cold test (TSCRcold)
Time Frame: Day 0
Skin temperature in supra-clavicular region will be recorded by infrared thermography (FLIR camera) during a cold test (feet in water at 19°C during 20min)
Day 0
Baseline difference in skin temperature in supra-clavicular region (diff TSCR)
Time Frame: Day 0
diff TSCR (day 0) = TSCRcold - TSCRbasal
Day 0

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cutaneous blood flow in supra-clavicular region in basal condition (PUbasal)
Time Frame: Day 0
Cutaneous blood flow in supra-clavicular region will be recorded by Laser Speckle Imaging (PeriCam) in basal condition
Day 0
Cutaneous blood flow in supra-clavicular region during a cold test (PUcold)
Time Frame: Day 0
Cutaneous blood flow in supra-clavicular region will be recorded by Laser Speckle Imaging (PeriCam) during a cold test (feet in water at 19°C during 20min)
Day 0
Baseline difference in cutaneous blood flow in supra-clavicular region (∆PU)
Time Frame: Day 0
diff PU (day0) =PUcold-PUbasal
Day 0
Volume of Brown Adipose Tissue detected by PET-CT
Time Frame: Day 0
18FDG PET-CT will be performed and volume will be segmented by PET/CT Viewer..
Day 0
Activity of Brown Adipose Tissue detected by PET-CT
Time Frame: Day 0
18FDG PET-CT will be performed and BAT activity (Standardized Uptake Value (SUV) will be segmented by PET/CT Viewer..
Day 0
Change from baseline difference in skin temperature in supra-clavicular region ( ∆ diffTSCR) at 12 months
Time Frame: Month 12
∆ diff TSCR = diff TSCR(month12) - diff TSCR (day0)
Month 12
Change from baseline difference in cutaneous blood flow in supra-clavicular region ( ∆ diff PU) at 12 months
Time Frame: Month 12
∆ diff PU = diff PU (month12) - diff PU (day0)
Month 12
Volume of Brown Adipose Tissue detected by PET-CT
Time Frame: Month 12
18FDG PET-CT will be performed and volume will be segmented by PET/CT Viewer..
Month 12
Activity of Brown Adipose Tissue detected by PET-CT
Time Frame: Month 12
18FDG PET-CT will be performed and BAT activity (Standardized Uptake Value (SUV) will be segmented by PET/CT Viewer..
Month 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Françoise Latil-Plat, Centre Hospitalier Henri Duffaut - Avignon

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 3, 2020

Primary Completion (ANTICIPATED)

November 3, 2023

Study Completion (ANTICIPATED)

March 3, 2024

Study Registration Dates

First Submitted

October 8, 2020

First Submitted That Met QC Criteria

October 23, 2020

First Posted (ACTUAL)

October 28, 2020

Study Record Updates

Last Update Posted (ACTUAL)

November 15, 2022

Last Update Submitted That Met QC Criteria

November 12, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pheochromocytoma

Clinical Trials on Infrared themrography

3
Subscribe